OP-06 program (Onco-Pharmakon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOP-06 program (Onco-Pharmakon)

Drug Alias Namemonoclonal antibody-drug conjugates (Onco-Pharmakon)OP-06

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Toxin

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryZambia

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOnco-Pharmakon Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOnco-Pharmakon Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A